DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Daranide (Dichlorphenamide) - Indications and Dosage

 
 



INDICATIONS AND USAGE

DARANIDE ® (dichlorphenamide tablets USP) is indicated for the treatment of elevated intraoculr pressure.

DOSAGE AND ADMINISTRATION

The recommended initial dosage for adults is 2 to 4 tablets (100-200 mg). Two tablets (100 mg) should be given every 12 hours until the desired dose response is obtained. The recommended maintenence dosage for adults is one-half to 1 tablet (25-50 mg) one to three times daily.

In acute angle-closure glaucoma, it may be used together with miotics and osmotic agents in an attempt to reduce intraocular pressure rapidly.

DOSAGE FORMS AND STRENGTHS

Round, yellow tablets, scored on one side, engraved with "TARO" on one side and on the other side "D" above the score and "50" below the score, 50 mg each.

HOW SUPPLIED/STORAGE AND HANDLING

Each DARANIDE® (dichlorphenamide tablets USP), 50 mg - round, yellow tablet, scored on one side, engraved with "TARO" on one side and on the other side "D" above the score and "50" below the score.

DARANIDE® (dichlorphenamide tablets USP) is supplied as follows:

Bottles of 30 NDC 51672-4144-6
Bottles of 100 NDC 51672-4144-1
Bottles of 1000 NDC 51672-4144-3
Unit Dose of 100 (10 ×10) NDC 51672-4144-0

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017